Physician profile
Summer Kay Jordan
NPI 1386313039
$5,044.41
in general payments reported to CMS, 2019-2025
51 companies · $3,624 in 2025
The $3,624 reported for 2025 was more than what 98% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $276 · 2023: $514 · 2024: $631 · 2025: $3,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,178 · Education: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,177.79 |
| Education | $590.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $385.44 | 2024-2025 | Rybrevant, Erleada, Carvykti |
| Merck Sharp & Dohme LLC | $339.10 | 2024-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Novartis Pharmaceuticals Corporation | $310.29 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $306.89 | 2025 | Libtayo |
| Vertos Medical, INC. | $270.63 | 2022-2024 | Mild Device Kit |
| Astellas Pharma US INC | $227.91 | 2024-2025 | Xtandi, Padcev |
| Astrazeneca Pharmaceuticals Lp | $215.71 | 2024-2025 | Enhertu, Calquence, Imfinzi |
| Incyte Corporation | $211.04 | 2025 | Jakafi, Monjuvi, Zynyz |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $192.20 | 2022-2023 | Relistor |
| Seagen INC. | $191.99 | 2025 | |
| Almatica Pharma LLC | $186.80 | 2022-2023 | Gralise |
| Eisai INC. | $152.92 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $146.91 | 2024-2025 | Opdivo |
| Glaxosmithkline, LLC. | $141.37 | 2025 | Ojjaara, Blenrep, Jemperli |
| Sobi, INC | $124.00 | 2025 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $123.47 | 2024-2025 | |
| Legend Biotech USA INC. | $95.06 | 2025 | Carvykti |
| Geron Corporation | $84.64 | 2024-2025 | Rytelo |
| Daiichi Sankyo INC. | $83.67 | 2024-2025 | Enhertu, Datroway |
| Gilead Sciences, INC. | $78.85 | 2025 | Trodelvy |
| Kite Pharma, INC. | $76.30 | 2025 | Yescarta |
| Bayer Healthcare Pharmaceuticals INC. | $74.69 | 2024-2025 | |
| Medline Industries Lp | $65.79 | 2025 | |
| Puma Biotechnology, INC. | $65.47 | 2024-2025 | |
| Kyowa Kirin, INC. | $59.42 | 2025 | |
| Abbvie INC. | $58.15 | 2022-2025 | |
| Beone Medicines USA, INC. | $55.12 | 2025 | Tevimbra |
| Ibsa Pharma INC. | $53.20 | 2022-2023 | Tirosint, Licart |
| Pharmaessentia USA Corporation | $43.50 | 2025 | Besremi |
| Alexion Pharmaceuticals, INC. | $43.03 | 2025 | Ultomiris |
| Novocure INC. | $42.06 | 2024-2025 | Optune Gio, Optune Lua (Novottf-200t) |
| Agios Pharmaceuticals, INC. | $40.44 | 2024-2025 | Pyrukynd |
| Dendreon Pharmaceuticals LLC | $38.55 | 2024 | Provenge |
| Blueprint Medicines Corporation | $37.04 | 2025 | Ayvakit |
| Array Biopharma INC | $36.53 | 2024-2025 | Mektovi, Tukysa, Braftovi |
| Jazz Pharmaceuticals INC. | $33.45 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $32.54 | 2023 | Belbuca |
| Recordati_rare_diseases_inc. | $30.87 | 2025 | Enjaymo |
| Genzyme Corporation | $30.38 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.45 | 2025 | Fruzaqla |
| Immunocore Limited | $27.25 | 2025 | Kimmtrak |
| Ipsen Biopharmaceuticals, INC | $26.08 | 2025 | Somatuline Depot, Onivyde |
| Lilly USA, LLC | $24.37 | 2025 | Jaypirca, Verzenio |
| Axonics, INC. | $23.48 | 2024 | Axonics |
| Servier Pharmaceuticals LLC | $23.35 | 2025 | |
| Sumitomo Pharma America, INC. | $19.96 | 2023 | Gemtesa |
| Sun Pharmaceutical Industries INC. | $19.85 | 2025 | |
| Pharmacosmos Therapeutics INC. | $18.66 | 2025 | Monoferric |
| Amgen INC. | $16.58 | 2022 | |
| Medtronic, INC. | $16.36 | 2023 | Intellis Adaptivestim |
| Hollister Incorporated | $13.60 | 2025 | New Image |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Summer Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.